Other protein tyrosine kinase

Other protein tyrosine kinase is a broad classification used to describe a diverse group of enzymes that catalyze the transfer of phosphate groups from ATP to tyrosine residues on protein substrates, but do not belong to major, well-characterized families such as the Epidermal Growth Factor Receptor (EGFR) or Vascular Endothelial Growth Factor Receptor (VEGFR) families [ChEMBL, NIH]. This category encompasses both receptor-type and non-receptor-type kinases, including members like PTK6 (Brk), PTK2 (FAK), and TNK2 (ACK1), which are essential for signal transduction, cell growth, and adhesion [UniProt, PubMed]. These kinases are frequently implicated in the progression of various malignancies and inflammatory diseases when their activity is dysregulated [NIH, StatPearls]. Many small-molecule inhibitors, such as dasatinib and sunitinib, are designed to target multiple kinases within this group to disrupt redundant signaling pathways in cancer cells [PubChem, PubMed]. However, the lack of specificity inherent in targeting a broad group of kinases often results in a complex safety profile, including potential off-target toxicities such as cardiotoxicity and myelosuppression [NIH, PubMed]. As a therapeutic category, it represents a significant area of research for developing multi-targeted therapies for heterogeneous diseases like cancer and chronic inflammation [NIH, PubMed]. The classification is primarily used in pharmacological databases to group compounds with broad-spectrum activity against tyrosine kinases that are not otherwise classified [ChEMBL].

Other names

Other protein tyrosine kinasesMiscellaneous tyrosine kinasesNon-classified tyrosine kinasesOther PTKs

Competitive inhibition of the ATP-binding site within the kinase domain of various tyrosine kinases [PubChem, PubMed].